Analyst Reco.

16/05/25 Schlumberger's Diversified Portfolio Caps Estimate Cuts After 'Light' Q1, Morgan Stanley Says MT
15/07/24 Piper Sandler Cuts ChampionX Price Target to $33 From $40, Maintains Neutral Rating MT
08/04/24 Piper Sandler Raises ChampionX's Price Target to $40 From $32, Maintains Neutral Rating MT
04/04/24 Barclays Raises Price Target on ChampionX to $51 From $39, Maintains Overweight Rating MT
03/04/24 RBC Raises Price Target on Schlumberger to $69 From $66 Amid ChampionX Deal, Keeps Outperform Rating MT
09/01/24 North American Morning Briefing : Samsung Warning -2- DJ
08/01/24 Piper Sandler Downgrades ChampionX to Neutral From Overweight, Adjusts Price Target to $32 From $38 MT
14/11/23 Goldman Sachs Cuts Price Target on ChampionX to $32 From $37, Maintains Neutral Rating MT
27/10/23 Piper Sandler Adjusts Price Target on ChampionX to $38 From $42, Maintains Overweight Rating MT
17/10/23 Barclays Upgrades ChampionX to Overweight Equal-Weight, Raises Price Target to $44 From $33 MT
14/07/23 Capital One Initiates ChampionX With Overweight Rating, $40 Price Target MT
05/04/23 Citigroup Trims Price Target on ChampionX to $40 From $41, Maintains Buy Rating MT
02/11/22 Goldman Sachs Adjusts ChampionX's Price Target to $32 From $21, Keeps Neutral Rating MT
01/11/22 Citigroup Adjusts ChampionX Price Target to $34 From $30, Maintains Buy Rating MT
06/10/22 Barclays Downgrades ChampionX to Equalweight From Overweight, Reduces Price Target to $28 From $38 MT
25/08/22 Analyst recommendations: Nvidia, Thermo Fisher Scientific, Danaher, Agilent Technologies, GDS Holdings... Zonebourse
25/08/22 Benchmark Starts ChampionX at Buy With $32 Price Target MT
15/07/22 BofA Securities Upgrades ChampionX to Buy From Neutral; Price Target is $22 MT
12/07/22 Goldman Sachs Lowers Price Target for ChampionX to $21 From $26, Maintains Neutral Rating MT
02/05/22 Barclays Adjusts ChampionX's Price Target to $38 from $33, Keeps Overweight Rating MT
11/04/22 Piper Sandler Lifts ChampionX to Overweight From Neutral, Price Target to $30 From $28 MT
11/03/22 BofA Securities Downgrades ChampionX to Neutral from Buy MT
22/02/22 Goldman Sachs Upgrades ChampionX to Neutral From Sell; Price Target is $24 MT
01/11/21 Barclays Adjusts Price Target on ChampionX to $35 From $29, Reiterates Overweight Rating MT
17/09/21 CHAMPIONX : Goldman Sachs Starts ChampionX at Sell With $22 Price Target MT
No results for this search